These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12052655)

  • 1. Introduction of in vitro data into local irritation/corrosion testing strategies by means of SAR considerations: assessment of chemicals.
    Gerner I; Schlede E
    Toxicol Lett; 2002 Feb; 127(1-3):169-75. PubMed ID: 12052655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro tests within the REACH information strategies.
    Louekari K; Sihvonen K; Kuittinen M; Sømnes V
    Altern Lab Anim; 2006 Aug; 34(4):377-86. PubMed ID: 16945005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the eye irritating properties of chemicals by applying alternatives to the Draize rabbit eye test: the use of QSARs and in vitro tests for the classification of eye irritation.
    Gerner I; Liebsch M; Spielmann H
    Altern Lab Anim; 2005 Jun; 33(3):215-37. PubMed ID: 16180977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.
    Graham JC; Wilt N; Costin GE; Villano C; Bader J; Krawiec L; Sly E; Gould J
    Cutan Ocul Toxicol; 2018 Dec; 37(4):380-390. PubMed ID: 30035615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Currently available in vitro methods used in the regulatory toxicology.
    Liebsch M; Spielmann H
    Toxicol Lett; 2002 Feb; 127(1-3):127-34. PubMed ID: 12052650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a decision support system for the introduction of alternative methods into local irritancy/corrosivity testing strategies. Creation of fundamental rules for a decision support system.
    Gerner I; Zinke S; Graetschel G; Schlede E
    Altern Lab Anim; 2000; 28(5):665-98. PubMed ID: 11091765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of existing (Q)SAR models for skin and eye irritation and corrosion to use for REACH registration.
    Verheyen GR; Braeken E; Van Deun K; Van Miert S
    Toxicol Lett; 2017 Jan; 265():47-52. PubMed ID: 27865849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CON4EI: CONsortium for in vitro Eye Irritation testing strategy - EpiOcular™ time-to-toxicity (EpiOcular ET-50) protocols for hazard identification and labelling of eye irritating chemicals.
    Kandarova H; Letasiova S; Adriaens E; Guest R; Willoughby JA; Drzewiecka A; Gruszka K; Alépée N; Verstraelen S; Van Rompay AR
    Toxicol In Vitro; 2018 Jun; 49():34-52. PubMed ID: 28866024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feasibility study developing an integrated testing strategy assessing skin irritation potential of chemicals.
    Hoffmann S; Saliner AG; Patlewicz G; Eskes C; Zuang V; Worth AP
    Toxicol Lett; 2008 Jul; 180(1):9-20. PubMed ID: 18585875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products.
    Indans I
    Toxicol Lett; 2002 Feb; 127(1-3):177-82. PubMed ID: 12052656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory use of (Q)SARs in toxicological hazard assessment strategies.
    Gerner I; Spielmann H; Hoefer T; Liebsch M; Herzler M
    SAR QSAR Environ Res; 2004; 15(5-6):359-66. PubMed ID: 15669695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CON4EI: Development of serious eye damage and eye irritation testing strategies with respect to the requirements of the UN GHS/EU CLP hazard categories.
    Verstraelen S; Van Rompay AR
    Toxicol In Vitro; 2018 Jun; 49():2-5. PubMed ID: 28629855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification and labeling of industrial products with extreme pH by making use of in vitro methods for the assessment of skin and eye irritation and corrosion in a weight of evidence approach.
    Scheel J; Heppenheimer A; Lehringer E; Kreutz J; Poth A; Ammann H; Reisinger K; Banduhn N
    Toxicol In Vitro; 2011 Oct; 25(7):1435-47. PubMed ID: 21550395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eye irritation.
    Eskes C; Bessou S; Bruner L; Curren R; Harbell J; Jones P; Kreiling R; Liebsch M; McNamee P; Pape W; Prinsen MK; Seidle T; Vanparys P; Worth A; Zuang V
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():47-81. PubMed ID: 16194141
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent progress in the eye irritation test.
    Chu IH; Toft P
    Toxicol Ind Health; 1993; 9(6):1017-25. PubMed ID: 8191500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to the assessment of eye and skin irritation.
    Calvin G
    Toxicol Lett; 1992 Dec; 64-65 Spec No():157-64. PubMed ID: 1471169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CON4EI: Development of testing strategies for hazard identification and labelling for serious eye damage and eye irritation of chemicals.
    Adriaens E; Verstraelen S; Alépée N; Kandarova H; Drzewiecka A; Gruszka K; Guest R; Willoughby JA; Van Rompay AR
    Toxicol In Vitro; 2018 Jun; 49():99-115. PubMed ID: 28964898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of eye irritation potential: statistical analysis and tier testing strategies.
    de Silva O; Cottin M; Dami N; Roguet R; Catroux P; Toufic A; Sicard C; Dossou KG; Gerner I; Schlede E; Spielmann H; Gupta KC; Hills RN
    Food Chem Toxicol; 1997 Jan; 35(1):159-64. PubMed ID: 9100818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ready-to-use integrated in vitro skin corrosion and irritation testing strategy using EpiSkin™ model in China.
    Liu Y; Li N; Chen L; Alépée N; Cai Z
    Toxicol In Vitro; 2020 Jun; 65():104778. PubMed ID: 31962199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory assessment of in vitro skin corrosion and irritation data within the European framework: Workshop recommendations.
    Eskes C; Detappe V; Koëter H; Kreysa J; Liebsch M; Zuang V; Amcoff P; Barroso J; Cotovio J; Guest R; Hermann M; Hoffmann S; Masson P; Alépée N; Arce LA; Brüschweiler B; Catone T; Cihak R; Clouzeau J; D'Abrosca F; Delveaux C; Derouette JP; Engelking O; Facchini D; Fröhlicher M; Hofmann M; Hopf N; Molinari J; Oberli A; Ott M; Peter R; Sá-Rocha VM; Schenk D; Tomicic C; Vanparys P; Verdon B; Wallenhorst T; Winkler GC; Depallens O
    Regul Toxicol Pharmacol; 2012 Mar; 62(2):393-403. PubMed ID: 22085589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.